A citation-based method for searching scientific literature

J Kevin Hicks, Christina L Aquilante, Henry M Dunnenberger, Roseann S Gammal, Ryan S Funk, Samuel L Aitken, David R Bright, James C Coons, Kierra M Dotson, Christopher T Elder, Lindsey T Groff, James C Lee. J Am Coll Clin Pharm 2019
Times Cited: 10

List of co-cited articles
33 articles co-cited >1

Times Cited
  Times     Co-cited

Emerging roles for pharmacists in clinical implementation of pharmacogenomics.
Aniwaa Owusu-Obeng, Kristin W Weitzel, Randy C Hatton, Benjamin J Staley, Jennifer Ashton, Rhonda M Cooper-Dehoff, Julie A Johnson. Pharmacotherapy 2014

Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey.
Aniwaa Owusu Obeng, Kezhen Fei, Kenneth D Levy, Amanda R Elsey, Toni I Pollin, Andrea H Ramirez, Kristin W Weitzel, Carol R Horowitz. J Pers Med 2018

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.
K R Crews, A Gaedigk, H M Dunnenberger, J S Leeder, T E Klein, K E Caudle, C E Haidar, D D Shen, J T Callaghan, S Sadhasivam,[...]. Clin Pharmacol Ther 2014

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu Rev Pharmacol Toxicol 2015

Primary care physicians' knowledge of and experience with pharmacogenetic testing.
S B Haga, W Burke, G S Ginsburg, R Mills, R Agans. Clin Genet 2012

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.
G C Bell, K E Caudle, M Whirl-Carrillo, R J Gordon, K Hikino, C A Prows, A Gaedigk, Jag Agundez, S Sadhasivam, T E Klein,[...]. Clin Pharmacol Ther 2017

Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges.
M J Arwood, S Chumnumwat, L H Cavallari, E A Nutescu, J D Duarte. Clin Transl Sci 2016

Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.
Mary V Relling, Matthias Schwab, Michelle Whirl-Carrillo, Guilherme Suarez-Kurtz, Ching-Hon Pui, Charles M Stein, Ann M Moyer, William E Evans, Teri E Klein, Federico Guillermo Antillon-Klussmann,[...]. Clin Pharmacol Ther 2019

Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis.
Maarten J Deenen, Didier Meulendijks, Annemieke Cats, Marjolein K Sechterberger, Johan L Severens, Henk Boot, Paul H Smits, Hilde Rosing, Caroline M P W Mandigers, Marcel Soesan,[...]. J Clin Oncol 2016

Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing.
Susanne B Haga, Ariel Kantor. Health Aff (Millwood) 2018

CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial.
D Max Smith, Kristin W Weitzel, Amanda R Elsey, Taimour Langaee, Yan Gong, Dyson T Wake, Benjamin Q Duong, Melanie Hagen, Christopher A Harle, Elvira Mercado,[...]. Genet Med 2019

Longitudinal exposure of English primary care patients to pharmacogenomic drugs: An analysis to inform design of pre-emptive pharmacogenomic testing.
James E Kimpton, Iain M Carey, Christopher J D Threapleton, Alexandra Robinson, Tess Harris, Derek G Cook, Stephen DeWilde, Emma H Baker. Br J Clin Pharmacol 2019

Opportunities for pharmacists to integrate pharmacogenomics into clinical practice.
Yan-Ting Wang, Man Yee Merl, Jun Yang, Zhi-Xiang Zhu, Guo-Hui Li. Pharmacogenomics J 2020

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing.
Larisa H Cavallari, Sara L Van Driest, Cynthia A Prows, Jeffrey R Bishop, Nita A Limdi, Victoria M Pratt, Laura B Ramsey, D Max Smith, Sony Tuteja, Benjamin Q Duong,[...]. Genet Med 2019

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
J A Johnson, K E Caudle, L Gong, M Whirl-Carrillo, C M Stein, S A Scott, M T Lee, B F Gage, S E Kimmel, M A Perera,[...]. Clin Pharmacol Ther 2017

Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.
Philip E Empey, James M Stevenson, Sony Tuteja, Kristin W Weitzel, Dominick J Angiolillo, Amber L Beitelshees, James C Coons, Julio D Duarte, Francesco Franchi, Linda J B Jeng,[...]. Clin Pharmacol Ther 2018

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
Kelly E Caudle, Teri E Klein, James M Hoffman, Daniel J Muller, Michelle Whirl-Carrillo, Li Gong, Ellen M McDonagh, Katrin Sangkuhl, Caroline F Thorn, Matthias Schwab,[...]. Curr Drug Metab 2014

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.
John F Greden, Sagar V Parikh, Anthony J Rothschild, Michael E Thase, Boadie W Dunlop, Charles DeBattista, Charles R Conway, Brent P Forester, Francis M Mondimore, Richard C Shelton,[...]. J Psychiatr Res 2019

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
Ursula Amstutz, Linda M Henricks, Steven M Offer, Julia Barbarino, Jan H M Schellens, Jesse J Swen, Teri E Klein, Howard L McLeod, Kelly E Caudle, Robert B Diasio,[...]. Clin Pharmacol Ther 2018

Integrating pharmacogenomics into electronic health records with clinical decision support.
J Kevin Hicks, Henry M Dunnenberger, Karl F Gumpper, Cyrine E Haidar, James M Hoffman. Am J Health Syst Pharm 2016

The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.
Mary V Relling, Teri E Klein, Roseann S Gammal, Michelle Whirl-Carrillo, James M Hoffman, Kelly E Caudle. Clin Pharmacol Ther 2020

Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
Marie-Pier Frigon, Marie-Ève Blackburn, Camélia Dubois-Bouchard, Ann-Lorie Gagnon, Suzie Tardif, Karine Tremblay. Pharmacogenomics 2019

Pharmacogenomics in the clinic.
Mary V Relling, William E Evans. Nature 2015

PharmGKB: A worldwide resource for pharmacogenomic information.
Julia M Barbarino, Michelle Whirl-Carrillo, Russ B Altman, Teri E Klein. Wiley Interdiscip Rev Syst Biol Med 2018

Implementation of a multidisciplinary pharmacogenomics clinic in a community health system.
Henry M Dunnenberger, Matthew Biszewski, Gillian C Bell, Annette Sereika, Holley May, Samuel G Johnson, Peter J Hulick, Janardan Khandekar. Am J Health Syst Pharm 2016

Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation Services.
J Kevin Hicks, David Stowe, Marc A Willner, Maya Wai, Thomas Daly, Steven M Gordon, Bret A Lashner, Sumit Parikh, Robert White, Kathryn Teng,[...]. Pharmacotherapy 2016

Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, Josh F Peterson, Jonathan D Burlison, Michelle Whirl-Carrillo, Stuart A Scott, Heidi L Rehm, Marc S Williams, Teri E Klein,[...]. Genet Med 2017

Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?
Rachel Huddart, Katrin Sangkuhl, Michelle Whirl-Carrillo, Teri E Klein. Clin Pharmacol Ther 2019

Transplant center volume and outcomes after liver retransplantation.
P P Reese, H Yeh, A M Thomasson, J Shults, J F Markmann. Am J Transplant 2009

A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation.
N Shuker, R Bouamar, R H N van Schaik, M C Clahsen-van Groningen, J Damman, C C Baan, J van de Wetering, A T Rowshani, W Weimar, T van Gelder,[...]. Am J Transplant 2016

Poor outcomes for children on the wait list at low-volume kidney transplant centers in the United States.
Abbas Rana, Eileen D Brewer, Brandi B Scully, Michael L Kueht, Matt Goss, Karim J Halazun, Hao Liu, N Thao N Galvan, Ronald T Cotton, Christine A O'Mahony. Pediatr Nephrol 2017

Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantation.
Kimberly M Deininger, Jacinda N Tran, Shirley M Tsunoda, Gordon K Young, Yee Ming Lee, Heather D Anderson, Robert L Page Ii, Jan D Hirsch, Christina L Aquilante. Pharmacogenomics 2019

Organizational structure and processes in pediatric heart transplantation: a survey of practices.
Gail Stendahl, Kathleen Bobay, Stuart Berger, Steven Zangwill. Pediatr Transplant 2012

Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties.
Katherine A Johansen Taber, Barry D Dickinson. Pharmgenomics Pers Med 2014

The effect of transplant center volume on survival after heart transplantation: a multicenter study.
Jeffrey H Shuhaiber, Jeff Moore, David B Dyke. J Thorac Cardiovasc Surg 2010

Attitudes of clinicians following large-scale pharmacogenomics implementation.
J F Peterson, J R Field, Y Shi, J S Schildcrout, J C Denny, T L McGregor, S L Van Driest, J M Pulley, I M Lubin, M Laposata,[...]. Pharmacogenomics J 2016

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy.
B Moriyama, A Owusu Obeng, J Barbarino, S R Penzak, S A Henning, S A Scott, Jag Agúndez, J R Wingard, H L McLeod, T E Klein,[...]. Clin Pharmacol Ther 2017

Perceptions of Personalized Medicine in an Academic Health System: Educational Findings.
Allison Vorderstrasse, Sara Huston Katsanis, Mollie A Minear, Nancy Yang, Tejinder Rakhra-Burris, Jason W Reeves, Robert Cook-Deegan, Geoffrey S Ginsburg, Leigh Ann Simmons. J Contemp Med Educ 2015

Optimization of initial tacrolimus dose using pharmacogenetic testing.
E Thervet, M A Loriot, S Barbier, M Buchler, M Ficheux, G Choukroun, O Toupance, G Touchard, C Alberti, P Le Pogamp,[...]. Clin Pharmacol Ther 2010

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.